ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Individuals with NAFLD/MASLD have been found to have lower serum adiponectin levels compared to healthy individuals, with these lower levels correlating with the severity of fibrosis, steatohepatitis, and liver inflammation.